Uncovering Rare Genetic Variants in Alzheimer’s
Alarm clock at 8 am. to wake up

Uncovering Rare Genetic Variants in Alzheimer’s

**Uncovering Rare Genetic Variants in Alzheimer’s: A Breakthrough in Understanding the Disease**

Alzheimer’s disease is a complex condition that affects millions of people worldwide. While we know that genetics play a significant role in its development, researchers have long been searching for specific genetic variants that could either increase or decrease the risk of the disease. Recently, scientists have made a groundbreaking discovery about a rare genetic variant that offers strong protection against Alzheimer’s disease in East Asian populations.

### A Rare Variant in the SORL1 Gene

A team of international researchers, led by Nancy Ip Yuk-yu from the Hong Kong University of Science and Technology, has identified a rare variant of the SORL1 gene called Hap_A. This variant is 168 times more prevalent in East Asian populations compared to Europeans. The SORL1 gene is crucial because it helps regulate the production and clearance of toxic amyloid-beta proteins, which can accumulate and damage brain cells, potentially leading to Alzheimer’s disease[1].

### How Does This Variant Work?

The researchers found that the Hap_A variant enhances the gene’s protein expression, thereby improving the regulation of amyloid-beta. This means that individuals with this variant are better at clearing out the toxic proteins that can cause brain damage. The study also identified a coding variant that regulates the expression and function of the SORL1 protein isoform, a topic that had not been comprehensively studied before[1].

### Implications for Alzheimer’s Research

This discovery is significant because it could pave the way for new anti-Alzheimer’s medications. By understanding how this protective variant works, scientists might be able to develop therapies aimed at targeting SORL1 to slow or prevent the progression of Alzheimer’s disease. The findings have been published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association and featured on Alzforum, a scholarly platform focused on Alzheimer’s research[1].

### Genetic Changes Linked to Ageing and Alzheimer’s

While the SORL1 variant is specific to East Asian populations, other genetic changes are linked to how cells respond to ageing and Alzheimer’s. Researchers at University College London found that certain genetic variants affect how brain cells function during ageing, either in a healthy way or in a way related to disease. These changes were observed in both humans and mice, but only humans showed significant genetic links to Alzheimer’s, suggesting that ageing in human brain cells might make them more susceptible to dementia[2].

### Biomarkers for Alzheimer’s

Another area of research involves using biomarkers to predict Alzheimer’s disease. Biomarkers are biological indicators that can signal the presence of a disease. Researchers at the Texas Alzheimer’s Research and Care Consortium used machine learning models to predict early Alzheimer’s disease among diverse patient populations. They found that a combination of biomarkers such as amyloid beta, tau, and neurofilament light chain were effective in predicting brain amyloidosis in different racial and ethnic groups[3].

### Conclusion

The discovery of the rare SORL1 variant in East Asian populations offers new hope for understanding and treating Alzheimer’s disease. By focusing on specific genetic variants, researchers can develop targeted therapies that could slow or prevent the progression of the disease. This breakthrough highlights the importance of international collaboration in genetic research and underscores the complex interplay between genetics, ageing, and Alzheimer’s disease.

As we continue to unravel the mysteries of Alzheimer’s, these findings remind us that there is still much to learn about this complex condition. However, with each new discovery, we move closer to finding effective treatments and ultimately, a cure for this devastating disease.